C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we
The Patient-Reported Outcome (PRO) Consortium: A Collaborative Approach to PRO Instrument Development and Qualification
Critical Path Institute’s Patient-Reported Outcome (PRO) Consortium: A Translatability Assessment Context
